Nanotechnology and molecular cytogenetics: the future has not yet arrived

Blastic Plasmacytoid Dendritic Cell Neoplasm; A Report of Three Cases

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematodermic myeloid malignancy that is known to be derived from plasmacytoid dendritic cells which are characterized by expression of CD4, CD56, and more specific markers such as CD123. Here, the authors present three cases of BPDCN diagnosed in the past two years and address different available diagnostic modalities such as morpho...

Diagnosis and Disease Management in CML Patients Using Conventional and Molecular Cytogenetics

Chronic Myeloid Leukemia (CML) is a hematopoietic malignancy characterized by the presence ofPhiladelphia (Ph1) chromosome that results from balanced reciprocal translocation between chromosomes9 and 22 leading in the formation of bcr/abl fusion gene. The present study was conducted to evaluate cytogenetic and molecular abnormalities in CML patients at presentation and during the co...

Review on Nanotechnology & Its Future Aspects

Nanotechnology is a new technology just in its infancy and being researched in labs all over the world. In principle any device that is manufactured to a nano-meter or even micro-meter scale would be considered to be nanotechnology. Nanotechnology refers to technology that is on a very small scale (atomic levels). It it not to be confused with what you see in science faction films, as the scien...

Cytoplasmic Her2/neu immunohistochemical staining in breast cancer; From a molecular point of view

Reviewing the nanotechnology in cosmeceuticals

Cosmeceuticals are the fastest growing segment of the personal care industry, and a number of topical cosmeceutical treatments for conditions such as photoaging, hyperpigmentation, wrinkles, and hair damage have come into widespread use. In the cosmeceutical arena nanotechnology has played an important role. Using new techniques to manipulate matter at an atomic or molecular level, opening up n...